Whitmore Lake’s Trace Medical Signs Deal for Tablo Hemodialysis System

Trace Medical in Whitmore Lake, a provider of advanced respiratory rentals and biomedical services, will partner with Outset Medical as part of a long-term distribution agreement to rent the Tablo Hemodialysis System to Home Medical Equipment (HME) providers.
148
Tablo Hemodialysis System
Trace Medical in Whitmore Lake reached a long-term distribution agreement with Outset Medical to rent the Tablo Hemodialysis System to Home Medical Equipment (HME) providers. // Photo courtesy of Outset Medical

Trace Medical in Whitmore Lake, a provider of advanced respiratory rentals and biomedical services, will partner with Outset Medical as part of a long-term distribution agreement to rent the Tablo Hemodialysis System to Home Medical Equipment (HME) providers.

As part of the agreement, Trace Medical will use its national distribution network to offer HME providers exclusive access to rent Tablo machines as a way of meeting the growing demand of dialysis patients seeking treatment at home.

Outset is a medical technology company out of California that’s developed technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System has been cleared for use by the FDA in hospital to the home environments. This can transform the dialysis experience for patients and operationally simplifies it for providers.

“We are excited to work with Outset to fill an obvious need in dialysis treatment,” says Greg Apostolou, CEO of Trace Medical. “Our chairman was recently diagnosed with renal disease and experienced first-hand the treatment gaps for patients. Together, we see an opportunity for Trace to utilize our national distribution platform and customer base which serves approximately 30 million patients annually to address these gaps.”

Tablo can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by anyone.

“Home hemodialysis is the future of dialysis care,” says Steve Williamson, chief commercial officer for Outset Medical. “This new agreement will provide us an additional opportunity to reach the over half million Americans that depend on dialysis to live.”

To support this initiative, Trace has established a dialysis advisory board with some of the industry’s most prominent nephrologists, Group Purchasing Organization leaders, and executives to help educate the industry about the benefits of home hemodialysis while also initiating discussions with publicly traded insurance companies about the clinical and financial benefits associated with home hemodialysis.